Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 6 of 6 entries
Sorted by: Best Match Show Resources per page
Barrett's oesophagus and adenocarcinoma.

World journal of surgical oncology

Caygill CP, Watson A, Lao-Sirieix P, Fitzgerald RC.
PMID: 15132744
World J Surg Oncol. 2004 May 07;2:12. doi: 10.1186/1477-7819-2-12.

No abstract available.

Cite
Caygill CP, Watson A, Lao-Sirieix P, et al. Barrett's oesophagus and adenocarcinoma. World J Surg Oncol. 2004;2:12doi: 10.1186/1477-7819-2-12.
Caygill, C. P., Watson, A., Lao-Sirieix, P., & Fitzgerald, R. C. (2004). Barrett's oesophagus and adenocarcinoma. World journal of surgical oncology, 212. https://doi.org/10.1186/1477-7819-2-12
Caygill, Christine P J, et al. "Barrett's oesophagus and adenocarcinoma." World journal of surgical oncology vol. 2 (2004): 12. doi: https://doi.org/10.1186/1477-7819-2-12
Caygill CP, Watson A, Lao-Sirieix P, Fitzgerald RC. Barrett's oesophagus and adenocarcinoma. World J Surg Oncol. 2004 May 07;2:12. doi: 10.1186/1477-7819-2-12. PMID: 15132744; PMCID: PMC420492.
Copy Download .nbib Format: NLM
The definition and management of Barrett's oesophagus: a case report, review of the literature and a suggestion for the future.

BMJ case reports

Bird-Lieberman EL, Lao-Sirieix P, Saeed I, Khoo D, Burnham R, Fitzgerald R.
PMID: 21686804
BMJ Case Rep. 2009;2009. doi: 10.1136/bcr.07.2008.0450. Epub 2009 Jun 01.

The definition of Barrett's oesophagus continues to evolve and there has been divergence in the diagnostic criteria internationally, which has implications for surveillance practices and research inclusion criteria. Here we describe the case of a 69-year-old female with 10...

Cite
Bird-Lieberman EL, Lao-Sirieix P, Saeed I, et al. The definition and management of Barrett's oesophagus: a case report, review of the literature and a suggestion for the future. BMJ Case Rep. 2009;2009doi: 10.1136/bcr.07.2008.0450.
Bird-Lieberman, E. L., Lao-Sirieix, P., Saeed, I., Khoo, D., Burnham, R., & Fitzgerald, R. (2009). The definition and management of Barrett's oesophagus: a case report, review of the literature and a suggestion for the future. BMJ case reports, 2009. https://doi.org/10.1136/bcr.07.2008.0450
Bird-Lieberman, Elizabeth Louise, et al. "The definition and management of Barrett's oesophagus: a case report, review of the literature and a suggestion for the future." BMJ case reports vol. 2009 (2009). doi: https://doi.org/10.1136/bcr.07.2008.0450
Bird-Lieberman EL, Lao-Sirieix P, Saeed I, Khoo D, Burnham R, Fitzgerald R. The definition and management of Barrett's oesophagus: a case report, review of the literature and a suggestion for the future. BMJ Case Rep. 2009;2009. doi: 10.1136/bcr.07.2008.0450. Epub 2009 Jun 01. PMID: 21686804; PMCID: PMC3029858.
Copy Download .nbib Format: NLM
Screening for oesophageal cancer.

Nature reviews. Clinical oncology

Lao-Sirieix P, Fitzgerald RC.
PMID: 22430857
Nat Rev Clin Oncol. 2012 Mar 20;9(5):278-87. doi: 10.1038/nrclinonc.2012.35.

Oesophageal cancer is a global health problem with high mortality due to the advanced nature of the disease at presentation; therefore, detection at an early stage significantly improves outcome. Oesophageal squamous-cell cancer is preceded by dysplasia and oesophageal adenocarcinoma...

Cite
Lao-Sirieix P, Fitzgerald RC. Screening for oesophageal cancer. Nat Rev Clin Oncol. 2012;9(5):278-87doi: 10.1038/nrclinonc.2012.35.
Lao-Sirieix, P., & Fitzgerald, R. C. (2012). Screening for oesophageal cancer. Nature reviews. Clinical oncology, 9(5), 278-87. https://doi.org/10.1038/nrclinonc.2012.35
Lao-Sirieix, Pierre, and Fitzgerald, Rebecca C. "Screening for oesophageal cancer." Nature reviews. Clinical oncology vol. 9,5 (2012): 278-87. doi: https://doi.org/10.1038/nrclinonc.2012.35
Lao-Sirieix P, Fitzgerald RC. Screening for oesophageal cancer. Nat Rev Clin Oncol. 2012 Mar 20;9(5):278-87. doi: 10.1038/nrclinonc.2012.35. PMID: 22430857.
Copy Download .nbib Format: NLM
Screening for oesophageal cancer.

Nature reviews. Clinical oncology

Lao-Sirieix P, Fitzgerald RC.
PMID: 22430857
Nat Rev Clin Oncol. 2012 Mar 20;9(5):278-87. doi: 10.1038/nrclinonc.2012.35.

Oesophageal cancer is a global health problem with high mortality due to the advanced nature of the disease at presentation; therefore, detection at an early stage significantly improves outcome. Oesophageal squamous-cell cancer is preceded by dysplasia and oesophageal adenocarcinoma...

Cite
Lao-Sirieix P, Fitzgerald RC. Screening for oesophageal cancer. Nat Rev Clin Oncol. 2012;9(5):278-87doi: 10.1038/nrclinonc.2012.35.
Lao-Sirieix, P., & Fitzgerald, R. C. (2012). Screening for oesophageal cancer. Nature reviews. Clinical oncology, 9(5), 278-87. https://doi.org/10.1038/nrclinonc.2012.35
Lao-Sirieix, Pierre, and Fitzgerald, Rebecca C. "Screening for oesophageal cancer." Nature reviews. Clinical oncology vol. 9,5 (2012): 278-87. doi: https://doi.org/10.1038/nrclinonc.2012.35
Lao-Sirieix P, Fitzgerald RC. Screening for oesophageal cancer. Nat Rev Clin Oncol. 2012 Mar 20;9(5):278-87. doi: 10.1038/nrclinonc.2012.35. PMID: 22430857.
Copy Download .nbib Format: NLM
Lectins in Cervical Screening.

Cancers

Lim AW, Neves AA, Lam Shang Leen S, Lao-Sirieix P, Bird-Lieberman E, Singh N, Sheaff M, Hollingworth T, Brindle K, Sasieni P.
PMID: 32708812
Cancers (Basel). 2020 Jul 16;12(7). doi: 10.3390/cancers12071928.

Cervical screening in low-resource settings remains an unmet need. Lectins are naturally occurring sugar-binding glycoproteins whose binding patterns change as cancer develops. Lectins discriminate between dysplasia and normal tissue in several precancerous conditions. We explored whether lectins could be...

Cite
Lim AW, Neves AA, Lam Shang Leen S, et al. Lectins in Cervical Screening. Cancers (Basel). 2020;12(7)doi: 10.3390/cancers12071928.
Lim, A. W., Neves, A. A., Lam Shang Leen, S., Lao-Sirieix, P., Bird-Lieberman, E., Singh, N., Sheaff, M., Hollingworth, T., Brindle, K., & Sasieni, P. (2020). Lectins in Cervical Screening. Cancers, 12(7), . https://doi.org/10.3390/cancers12071928
Lim, Anita Ww, et al. "Lectins in Cervical Screening." Cancers vol. 12,7 (2020). doi: https://doi.org/10.3390/cancers12071928
Lim AW, Neves AA, Lam Shang Leen S, Lao-Sirieix P, Bird-Lieberman E, Singh N, Sheaff M, Hollingworth T, Brindle K, Sasieni P. Lectins in Cervical Screening. Cancers (Basel). 2020 Jul 16;12(7). doi: 10.3390/cancers12071928. PMID: 32708812; PMCID: PMC7409129.
Copy Download .nbib Format: NLM
Glucose transporter 1 expression as a marker of prognosis in oesophageal adenocarcinoma.

Oncotarget

Blayney JK, Cairns L, Li G, McCabe N, Stevenson L, Peters CJ, Reid NB, Spence VJ, Chisambo C, McManus D, James J, McQuaid S, Craig S, Arthur K, McArt D, Ong CJ, Lao-Sirieix P, Hamilton P, Salto-Tellez M, Eatock M, Coleman HG, Fitzgerald RC, Kennedy RD, Turkington RC.
PMID: 29719622
Oncotarget. 2018 Apr 06;9(26):18518-18528. doi: 10.18632/oncotarget.24906. eCollection 2018 Apr 06.

BACKGROUND: The current TNM staging system for oesophageal adenocarcinoma (OAC) has limited ability to stratify patients and inform clinical management following neo-adjuvant chemotherapy and surgery.RESULTS: Functional genomic analysis of the gene expression data using Gene Set Enrichment Analysis (GSEA)...

Cite
Blayney JK, Cairns L, Li G, et al. Glucose transporter 1 expression as a marker of prognosis in oesophageal adenocarcinoma. Oncotarget. 2018;9(26):18518-18528doi: 10.18632/oncotarget.24906.
Blayney, J. K., Cairns, L., Li, G., McCabe, N., Stevenson, L., Peters, C. J., Reid, N. B., Spence, V. J., Chisambo, C., McManus, D., James, J., McQuaid, S., Craig, S., Arthur, K., McArt, D., Ong, C. J., Lao-Sirieix, P., Hamilton, P., Salto-Tellez, M., Eatock, M., Coleman, H. G., Fitzgerald, R. C., Kennedy, R. D., Turkington, R. C. (2018). Glucose transporter 1 expression as a marker of prognosis in oesophageal adenocarcinoma. Oncotarget, 9(26), 18518-18528. https://doi.org/10.18632/oncotarget.24906
Blayney, Jaine K, et al. "Glucose transporter 1 expression as a marker of prognosis in oesophageal adenocarcinoma." Oncotarget vol. 9,26 (2018): 18518-18528. doi: https://doi.org/10.18632/oncotarget.24906
Blayney JK, Cairns L, Li G, McCabe N, Stevenson L, Peters CJ, Reid NB, Spence VJ, Chisambo C, McManus D, James J, McQuaid S, Craig S, Arthur K, McArt D, Ong CJ, Lao-Sirieix P, Hamilton P, Salto-Tellez M, Eatock M, Coleman HG, Fitzgerald RC, Kennedy RD, Turkington RC. Glucose transporter 1 expression as a marker of prognosis in oesophageal adenocarcinoma. Oncotarget. 2018 Apr 06;9(26):18518-18528. doi: 10.18632/oncotarget.24906. eCollection 2018 Apr 06. PMID: 29719622; PMCID: PMC5915089.
Copy Download .nbib Format: NLM
Showing 1 to 6 of 6 entries